Month: April 2021

MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580,000 shares of its common stock at a price of $20.00 per share, for gross proceeds of $131.6 million, before underwriting discounts and commissions and offering expenses payable by Akoya. Akoya has also granted the underwriters a 30-day option to purchase up to an additional 987,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. All shares are being offered and sold by Akoya. The shares are expected to begin trading on the Nasdaq Global Select Market on April 16, 2021 under the ticker symbol “AKYA.” The offering is expected to close on April 20, 2021, subject to the satisfaction...

New York, New York, April 15, 2021 (GLOBE NEWSWIRE) — Global SPAC Partners Co. (“Global” or the “Company”) (NASDAQ: GLSPU) announced today that an additional 750,000 units were issued on April 14, 2021 pursuant to the underwriters’ over-allotment option in connection with its initial public offering. The offering was priced at $10.00 per unit, generating additional gross proceeds of $7,500,000 and bringing the total gross proceeds of the initial public offering to $167,500,000. The remaining underwriters’ over-allotment option will not be exercised. The Company’s units began trading on the NASDAQ Capital Market (“NASDAQ”) on April 9, 2021, under the ticker symbol “GLSPU.” Each unit consists of one subunit and one-half of a redeemable warrant. Each subunit consists of one Class A ordinary share and one-quarter of a redeemable warrant. Each...

CARLSBAD, Calif., April 15, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $19.50 per share. The gross proceeds to SeaSpine, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $87.8 million. The offering is expected to close on or about April 20, 2021, subject to customary closing conditions. Piper Sandler & Co., Canaccord Genuity LLC and Stifel are acting as joint book-running managers, Truist Securities, Inc. is acting as lead manager and BTIG,...

FORT MILL, S.C., April 15, 2021 (GLOBE NEWSWIRE) — Diversey Holdings, Ltd. (Nasdaq:DSEY) (“Diversey”), a leading provider of hygiene, infection prevention and cleaning solutions, today announced that the underwriters of the previously announced and closed initial public offering of 46,153,846 ordinary shares exercised their option and purchased an additional 5,000,000 ordinary shares at the initial public offering price of $15.00, less the underwriting discount, which purchase of additional shares has also previously closed. The estimated net proceeds from the offering, including the exercise of the underwriters’ option, are approximately $723 million after deducting the underwriting discount and estimated offering expenses. The total number of ordinary shares outstanding after the offering is 309,008,357. Citigroup, Morgan Stanley,...

FORT LAUDERDALE, Fla. and NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) — SEACOR Holdings Inc. (“SEACOR” or the “Company”) and American Industrial Partners (“AIP”) today announced the completion of the acquisition of SEACOR by AIP and its affiliates following their receipt of 70.4% of outstanding shares validly tendered as of the expiration time of the tender offer. “Today marks an important milestone for SEACOR. I am confident in the Company’s smooth transition to a private company and look forward to seeing the Company’s continued success in partnership with AIP,” said Charles Fabrikant, Founder of SEACOR. “We’re excited to complete this transaction and become part of the AIP family,” said Eric Fabrikant, Chief Executive Officer of SEACOR. “Going forward, SEACOR will have greater financial flexibility to execute our strategy and pursue...

HOUSTON, April 15, 2021 (GLOBE NEWSWIRE) — Altus Midstream Company (Nasdaq: ALTM) (“Altus”) will host its first-quarter 2021 results conference call Thursday, May 6, 2021 at 1 p.m. Central time. The company will issue its earnings release after close of market Wednesday, May 5. The full text of the release will be available on the company’s website at www.altusmidstream.com. The conference call will be webcast from Altus’ website at www.altusmidstream.com/investors, and the webcast replay will be archived there as well. The conference call will also be available for playback by telephone for one week beginning at approximately 6 p.m. Central time May 6. To access the telephone playback, dial (855) 859-2056 or (404) 537-3406 for international calls. The conference access code is 3586726. About Altus Midstream Company Altus Midstream...

HOUSTON, April 15, 2021 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today provided supplemental information regarding certain first-quarter 2021 financial and operational results. Supplemental quarterly informationTo further assist analysts with their first-quarter earnings models, the company is providing the following estimates:Estimated Average Realized Prices – 1Q21  Oil (bbl) NGL (bbl) Natural Gas (Mcf)United States $57.00 $23.00 $4.40International $61.00 $47.50 $3.40Egypt tax barrels:  24-25 MBoe/dRealized gain on commodity derivatives (before tax):  $148 millionUnrealized gain on commodity derivatives (before tax): $26 millionDry hole costs (before tax):  $19-23 millionNet loss on oil and gas purchases and sales (before tax): $54 millionFirst-quarter 2021 production guidance updateAPA...

VANCOUVER, British Columbia and TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Clean Power Capital Corp. (CSE: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Power” or the “Company” or “MOVE”). The Company is pleased to announce that it has entered into a definite agreement to make an investment in FusionOne Energy Corp. (“FusionOne”), a producer of technologies primarily for the conversion of plastic waste to hydrogen and clean electricity. One of the principals of FusionOne has developed proprietary, patented pending technologies for the thermal processing of plastics and other carbon matter into clean “white” hydrogen and electricity, this gives the opportunity to recognize the breadth of technologies central to Company’s investment philosophy. The cutting-edge solution integrates an internally developed, market-leading efficiency,...

TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR) is pleased to announce that it will be featured as a presenting company at the H.C Wainwright Spring Mining Conference. The mining conference, being held virtually on April 19-20, 2021, will have Bunker Hill Mining present on Tuesday, April 20, 2021 at 1:30pm EST. Sam Ash, Chief Executive Officer and David Wiens, Chief Financial Officer will provide a live overview of the Company’s strategic vision, and will be available to participate in one-on-one meetings with qualified members of the investment community who are registered to attend the conference.   For more information, please visit the conference website (www.hcwevents.com/mining). About Bunker Hill Mining Corp. Under new Idaho-based leadership the Bunker Hill Mining Corp, intends...

YONKERS, N.Y., April 15, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced that Cara Cassino, MD, Chief Medical Officer and Executive Vice President of Research, will virtually present the Company’s anti-infective portfolio and platform technology of DLAs in the session on “Advancing Clinical Superiority of Anti-Infectives to Drive Commercial Success.” Dr. Cassino’s presentation will focus on the powerful antimicrobial attributes of DLAs which underpin the potential for superior clinical outcomes for serious, life-threatening, and critically underserved...